ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

FDBK Feedback Plc

60.50
0.00 (0.00%)
19 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Feedback Plc LSE:FDBK London Ordinary Share GB00BJN59X09 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 60.50 60.00 61.00 60.50 60.50 60.50 14,770 07:44:37
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Computers 1.03M -2.92M -0.2188 -2.77 8.07M
Feedback Plc is listed in the Electronic Computers sector of the London Stock Exchange with ticker FDBK. The last closing price for Feedback was 60.50p. Over the last year, Feedback shares have traded in a share price range of 58.00p to 150.00p.

Feedback currently has 13,334,659 shares in issue. The market capitalisation of Feedback is £8.07 million. Feedback has a price to earnings ratio (PE ratio) of -2.77.

Feedback Share Discussion Threads

Showing 7826 to 7850 of 14875 messages
Chat Pages: Latest  319  318  317  316  315  314  313  312  311  310  309  308  Older
DateSubjectAuthorDiscuss
15/1/2020
01:24
They could replace them before giving to hospitals and airports. Or have an upgrade to the product before release.
demonboy
14/1/2020
19:17
They manufacture fluoroscopy systems, the main users are hospitals and airport security.
lr2
14/1/2020
19:04
Toshiba, canon and Siemens are users of fluoroscopic systems and could benefit.
demonboy
14/1/2020
19:03
Toshiba, canon, Siemens are users of fluoroscopic systems
demonboy
14/1/2020
16:32
come home from picking the kids up from school and see this. lovely
davydoo
14/1/2020
16:25
I’ll get my coat!
ducatiman
14/1/2020
16:09
Careful Duc. Knowing you'd be back about now I just checked limits again. I think there's a large sell waiting to see daylight as you can now buy over 1 million at 1.036p.
lr2
14/1/2020
16:07
I see my crystal ball is working well. It says news imminent, lol.
ducatiman
14/1/2020
15:56
I agree with you Yump about the slowness of the NHS. My sister had a heart op last May which didn't improve her condition one bit. She has been waiting for another op since then and has just been given a provisional date of mid-February. There's something seriously wrong with the NHS if this is the kind of turnaround they provide.

When Bleepa was being developed, it was small scale tested within the Polish Health Service. It would not surprise me to find out that Narodowy Fundusz Zdrowia takes it on before the NHS make a decision.

lr2
14/1/2020
15:51
You're right. Here news from few months ago.In the review, the board assessed both its Cadran and the TexRAD portfolios. The Cadran portfolio has been initially prioritised.
demonboy
14/1/2020
15:43
I haven't followed long enough to have noticed so thanks for that.

I'm certainly not impatient for Bleepa trial news - things just do not go at that speed generally, particularly in the NHS. This will be a good test of whether the NHS is actually capable at all of adopting anything quickly. Not sure I'm looking forward to the answer to that, but at least its a relatively simple product and doesn't need all the peer-assessments and ineffective NICE reports. Budgets are something else though.

yump
14/1/2020
15:37
Yump, it leaks like a sieve before every placing but not so much on good news. 18 trades and a 2.5% rise is insignificant in the greater picture.
lr2
14/1/2020
15:34
Too early to roll out Bleepa as trial is still ongoing. They will be analyzing feedback from the trial and looking to add high priority changes to next version before moving forward with a roll out. They have a project manager on this project and he will be advising the BoD on how to do things properly and in clear order of incremental improvement if he is good at his job. Doubt any big news on Bleepa before the daffodils flower this springtime.

Far more interesting might be the move of TexRAD from research into clinical sales. The Imaging Endpoints news points in that direction.

lr2
14/1/2020
15:29
Has the share risen before news in the past ? - that would be an indication of leakiness - otherwise its just punting buys.
yump
14/1/2020
15:21
Maybe news to come on more contracts and rollout of bleepa
demonboy
14/1/2020
15:15
Yep. Got some price movement.

Current on line limits are:

Buy 475k at 1.05p (smaller amounts at 1.035p).
Sell 1.5m at 0.9625p (smaller amounts at 0.97p).

lr2
14/1/2020
15:04
Big blues lost of them.
demonboy
14/1/2020
14:38
Right, I am jumping on the M6, will check in in about 90mins, I expect some blue!
ducatiman
14/1/2020
14:35
Encouraging, ty LR2.
ducatiman
14/1/2020
14:34
Current on line limits are:

Buy 500k at 0.985p (smaller amounts at same price).
Sell 1.5m at 0.9625p (smaller amounts at same price).

lr2
14/1/2020
14:29
You can LR2 doesn’t look like Petek is about today, lol.
ducatiman
14/1/2020
14:28
haha. that wasn't me. 450k today for me
davydoo
14/1/2020
14:28
I meant doubled up on today's purchases.

Suppose I ought to check on the limits again.

lr2
14/1/2020
14:26
Doubled up? I think he’s sitting on just under 6m now!
ducatiman
14/1/2020
14:25
Has Davydoo just doubled up with the 500k trade?
lr2
Chat Pages: Latest  319  318  317  316  315  314  313  312  311  310  309  308  Older

Your Recent History

Delayed Upgrade Clock